Bid by India's largest generic drug group for the Swedish company would be worth at least $4bn, at a time of consolidation in the off-patent industry Source
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,